<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2019</year>
	<month>10</month>
	<day>15</day>
</pubdate>
<volume>20</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>31897392</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>The Contingent Prenatal Screening Test for Down’s Syndrome and Neural Tube Defects in West of Iran</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The purpose of the study was to evaluate the use of contingent prenatal screening for the detection of Down&amp;rsquo;s syndrome and neural tube defects (NTDs) in west of Iran.&lt;br /&gt;
Methods: A prospective study was conducted on 653 pregnant women referred to a medical diagnostic laboratory (Imam Reza Clinic, Kermanshah, Iran) for contingent prenatal screening tests between October 2016 to September 2017.&amp;nbsp;&lt;br /&gt;
Results: Among 651 women screened in the first trimester, 8 (1.22%) pregnancies were screen-positive for Down&amp;rsquo;s syndrome. In the second trimester, among 605 women, 25 (4.13%) had a positive result and all of these women voluntarily underwent amniocentesis. Overall, five pregnancies were complicated with chromosomal abnormalities, including five cases of Down&amp;rsquo;s syndrome.&amp;nbsp;&lt;br /&gt;
Conclusion: In a nutshell, the contingent prenatal screening tests were found to be useful for estimation of Down&amp;rsquo;s syndrome as well as NTDs in both young and older mothers in west of Iran. These tests should be performed for pregnant women before an invasive test for Down&amp;rsquo;s syndrome.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Contingent prenatal screening test, Down syndrome, Iran, Neural tube defects</keyword>
	<start_page>244</start_page>
	<end_page>252</end_page>
	<web_url>https://www.jri.ir/article/60055</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/60055.pdf</pdf_url>
	<author_list><author><first_name>Faranak</first_name><middle_name></middle_name><last_name>Aghaz</last_name><suffix></suffix><affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>61942</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Seyyedeh Zeinab</first_name><middle_name></middle_name><last_name>Ojagh</last_name><suffix></suffix><affiliation>Imamreza Clinic, Kermanshah, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>61943</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Saber</first_name><middle_name></middle_name><last_name>Khanjari</last_name><suffix></suffix><affiliation> Gene targeting Lab, John Curtin School of Medical Research, The Australian National University, Kermanshah, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>61944</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Asad</first_name><middle_name></middle_name><last_name>Vaisi-Raygani</last_name><suffix></suffix><affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation><first_name_fa>Asad</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>Vaisi-Raygani</last_name_fa><suffix_fa></suffix_fa><email>avaisiraygani@gmail.com</email><code>1177</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mozaffar</first_name><middle_name></middle_name><last_name>Khazaei</last_name><suffix></suffix><affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation><first_name_fa> مظفر</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>خزاعی</last_name_fa><suffix_fa></suffix_fa><email></email><code>578</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mitra</first_name><middle_name></middle_name><last_name>Bakhtiari</last_name><suffix></suffix><affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>31882</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

